This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Airgas And Biologics Modular Announce Marketing Agreement To Provide Modular Research Suites For Life Sciences And Pharmaceutical Customers

Airgas, Inc. (NYSE: ARG) and Biologics Modular, LLC today jointly announced a three-year marketing, sales, and service agreement to provide modular facilities to serve as self-contained bio-repositories, bio-manufacturing sites, and research suites for health service providers, educational facilities, and pharmaceutical manufacturers. Airgas will provide the specialty gases and equipment, cryogenic liquids and freezers, and laboratory design services while Biologics Modular will manufacture, fit out, and deliver the modular suites and provide site preparation.

“Many of our customers recognize the need to expand their life science assets but may have budget or facility constraint issues,” said Todd Morris, Airgas vice-president – university and laboratory markets. “The Biologics Modular platform enables us to provide a flexible, cost-effective solution. Self-contained modular suites fully outfitted with the necessary equipment and gases or cryogenics serve as a viable short-term, and in some cases, permanent, solution.”

“Partnering with a company of the caliber of Airgas allows us to expand our sales and marketing to a larger channel of research, laboratory and pharmaceutical manufacturers,” said Clark H. Byrum, Jr., President and CEO of Biologics Modular. “Their experience with leading research institutions and life science companies, coupled with our innovative facilities platform, provides access to a broader array of solutions for our customers. We look forward to working with Airgas and their life science team in delivering a combined facility solution to our customers.”

About Airgas, Inc.

Airgas, Inc. (NYSE: ARG), through its subsidiaries, is one of the nation’s leading suppliers of industrial, medical and specialty gases, and hardgoods, such as welding equipment and related products. Airgas is a leading U.S. producer of atmospheric gases with 16 air separation plants, a leading producer of carbon dioxide, dry ice, and nitrous oxide, one of the largest U.S. suppliers of safety products, and a leading U.S. supplier of refrigerants, ammonia products, and process chemicals. More than 15,000 employees work in approximately 1,100 locations, including branches, retail stores, gas fill plants, specialty gas labs, production facilities and distribution centers. Airgas also markets its products and services through eBusiness, catalog and telesales channels. Its national scale and strong local presence offer a competitive edge to its diversified customer base. For more information, please visit www.airgas.com.

About Biologics Modular

Headquartered in Brownsburg, IN, Biologics Modular, LLC designs, manufactures, and sells modular facilities to serve as self-contained bio-repositories, bio-manufacturing suites, and research suites to health science service providers, educational facilities, and pharmaceutical manufacturers. For more information, please visit www.biologicsmodular.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50471515&lang=en



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,915.07 -70.54 -0.42%
S&P 500 1,964.68 -8.15 -0.41%
NASDAQ 4,396.2040 -22.83 -0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs